Vitamin d deficiency and Paranasal sinus hypersecretion
Paranasal sinus hypersecretion is reported only by a few people with Vitamin d deficiency.
The study analyzes which people have Paranasal sinus hypersecretion with Vitamin d deficiency. It is created by eHealthMe based on 3 people who have Paranasal sinus hypersecretion and Vitamin d deficiency from the Food and Drug Administration (FDA), and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
3 people who have Vitamin D Deficiency and Paranasal Sinus Hypersecretion are studied.
What is Vitamin d deficiency?
Vitamin d deficiency is found to be associated with 1,920 drugs and 1,344 conditions by eHealthMe.
What is Paranasal sinus hypersecretion?
Paranasal sinus hypersecretion is found to be associated with 729 drugs and 395 conditions by eHealthMe.
Number of Paranasal sinus hypersecretion in Vitamin d deficiency reports submitted per year:
Gender of people who have Vitamin D Deficiency and experienced Paranasal Sinus Hypersecretion *:
- female: 100 %
- male: 0.0 %
Age of people who have Vitamin D Deficiency and experienced Paranasal Sinus Hypersecretion *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 33.33 %
- 60+: 66.67 %
Common co-existing conditions for these people *:
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 66.67%
- Wheezing (a high-pitched whistling sound made while you breath): 1 person, 33.33%
- Torticollis (a twisted neck in which the head is tipped to one side, while the chin is turned to the other): 1 person, 33.33%
- Rheumatoid Vasculitis (inflammation of veins with painful joints and morning stiffness): 1 person, 33.33%
- Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 33.33%
- Pain: 1 person, 33.33%
- Oedema (fluid collection in tissue): 1 person, 33.33%
- Muscle Spasms (muscle contraction): 1 person, 33.33%
- Muscle Aches (muscle pain): 1 person, 33.33%
- Hypersensitivity: 1 person, 33.33%
Common drugs taken by these people *:
- Vitamin D3: 2 people, 66.67%
- Xeljanz Xr: 1 person, 33.33%
- Botox: 1 person, 33.33%
- Calcium: 1 person, 33.33%
- Depo-Medrol: 1 person, 33.33%
- Enbrel: 1 person, 33.33%
- Fish Oil: 1 person, 33.33%
- Flexeril: 1 person, 33.33%
- Humira: 1 person, 33.33%
- Klor-Con M20: 1 person, 33.33%
Common symptoms for these people *:
- Headache (pain in head): 3 people, 100.00%
- Insomnia (sleeplessness): 3 people, 100.00%
- Pain: 3 people, 100.00%
- Oedema Peripheral (superficial swelling): 2 people, 66.67%
- Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 2 people, 66.67%
- Weakness: 2 people, 66.67%
- Night Sweats (sweating in night): 2 people, 66.67%
- Dry Eyes (lack of adequate tears): 2 people, 66.67%
- Hypoaesthesia (reduced sense of touch or sensation): 2 people, 66.67%
- Osteoarthritis (a joint disease caused by cartilage loss in a joint): 2 people, 66.67%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Paranasal sinus hypersecretion?Check whether Paranasal sinus hypersecretion is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Treatments, associated drugs and conditions:
COVID vaccines that are related to Paranasal sinus hypersecretion:
- Paranasal sinus hypersecretion in Moderna COVID Vaccine
- Paranasal sinus hypersecretion in Pfizer BioNTech Covid Vaccine
- Paranasal sinus hypersecretion in Johnson and Johnson Covid Vaccine
Common drugs associated with Paranasal sinus hypersecretion:
All the drugs that are associated with Paranasal sinus hypersecretion:
- Paranasal sinus hypersecretion (729 drugs)
Common conditions associated with Paranasal sinus hypersecretion:
All the conditions that are associated with Paranasal sinus hypersecretion:
- Paranasal sinus hypersecretion (395 conditions)
How the study uses the data?
The study is based on Paranasal sinus hypersecretion and Vitamin d deficiency, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Haldol and Akinesia - 18 seconds ago
- Metoprolol Tartrate and Haemorrhage - 24 seconds ago
- Itraconazole and Aseptic Necrosis - 35 seconds ago
- Folic Acid and Foot Deformity - 42 seconds ago
- Nevanac and Optic Neuritis - 45 seconds ago
- Gastrointestinal Ulcer and Vomiting Aggravated - 45 seconds ago
- Cabometyx and Combivent Respimat drug interaction - 48 seconds ago
- Claritin-D and Lansoprazole drug interaction - a minute ago
- Pantoprazole Sodium and Gouty Arthritis - a minute ago
- Erythromycin and Reopro drug interaction - a minute ago